Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Topic Paragraphs
FDA Hearing on the Center for Drug Evaluation and Research’s proposal to withdraw approval of Makena occurring on October 17-19, 2022
Featured Topics
FDA Monkeypox Response
The FDA’s multipronged response to monkeypox includes efforts in the areas of diagnostics, vaccines and therapeutics.
Infant Formula Information and Resources
The FDA continues to work around the clock with our government partners and industry to ensure there's adequate infant formula available wherever and whenever parents and caregivers need it.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Nov 03
Kalera Voluntarily Recalls Fresh Lettuce Products Because of Possible Health Risk
Food & Beverages
Nov 03
Nestlé USA Announces Voluntary Recall of Limited Quantity of Edible Chocolate Chip Cookie Dough Tubs from NESTLÉ® TOLL HOUSE® Due to Potential Presence of Foreign Material
Food & Beverages
Nov 03
Teleflex Announces Worldwide Recall of Gibeck® Iso-Gard® Filter
Medical Devices
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Continues to Advance Medicines for Children
Increasing the availability of safe and effective medicines for children is a key priority for the U.S. Food and Drug Administration.
FDA Seeks Feedback on Distributed and Point-of-Care Drug Manufacturing
These technologies could potentially provide flexibility for drug manufacturers to increase timely access to quality drugs.
FDA Releases New, Prevention Strategies to Enhance Food Safety
The strategies contain recommendations to guide the work of preventing future foodborne illnesses.